Cargando…

Nesfatin-1 protects against diabetic cardiomyopathy in the streptozotocin-induced diabetic mouse model via the p38-MAPK pathway

Nesfatin-1 is a novel anorexigenic peptide that possesses antihyperglycemic and cardiovascular effects. We hypothesized that nesfatin-1 has a beneficial protective effect against diabetic cardiomyopathy (DC). We investigated the therapeutic effect of nesfatin-1 on diabetes-associated cardiac dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Zhanwei, Dong, Jianjiang, Mu, Yindong, Liu, Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9342195/ https://www.ncbi.nlm.nih.gov/pubmed/35818327 http://dx.doi.org/10.1080/21655979.2022.2066748

Ejemplares similares

Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice
por: Wu, Bin, et al.
Publicado: (2017)

Spironolactone Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Liu, Wenjuan, et al.
Publicado: (2018)

The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy
por: Wang, Shudong, et al.
Publicado: (2016)

Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway
por: Han, Jiarui, et al.
Publicado: (2020)

The Protective Effect of Beraprost Sodium on Diabetic Nephropathy by Inhibiting Inflammation and p38 MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Rats
por: Peng, Li, et al.
Publicado: (2016)

Forskolin Protected against Streptozotocin-Induced Diabetic Cardiomyopathy via Inhibition of Oxidative Stress and Cardiac Fibrosis in Mice
por: Zhang, Xu, et al.
Publicado: (2021)

The Protective Effect of Beraprost Sodium on Diabetic Cardiomyopathy through the Inhibition of the p38 MAPK Signaling Pathway in High-Fat-Induced SD Rats
por: Li, Jie, et al.
Publicado: (2014)

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
por: Wu, Meng, et al.
Publicado: (2018)

Thymoquinone Attenuates Cardiomyopathy in Streptozotocin-Treated Diabetic Rats
por: Atta, Mustafa S., et al.
Publicado: (2018)

Dendropanax morbifera Protects against Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Sachan, Richa, et al.
Publicado: (2020)

Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats
por: Fan, Yuyan, et al.
Publicado: (2019)

Duration of streptozotocin-induced diabetes differentially affects p38-mitogen-activated protein kinase (MAPK) phosphorylation in renal and vascular dysfunction
por: Chen, Hongmei, et al.
Publicado: (2005)

Fisetin protects against streptozotocin-induced diabetic cardiomyopathy in rats by suppressing fatty acid oxidation and inhibiting protein kinase R
por: ALTamimi, Jozaa Z., et al.
Publicado: (2021)

Syringic Acid Attenuates Cardiomyopathy in Streptozotocin-Induced Diabetic Rats
por: Sabahi, Zahra, et al.
Publicado: (2021)

Edaravone Protect against Retinal Damage in Streptozotocin-Induced Diabetic Mice
por: Yuan, Dongqing, et al.
Publicado: (2014)

Proanthocyanidins Protect Against Cadmium-Induced Diabetic Nephropathy Through p38 MAPK and Keap1/Nrf2 Signaling Pathways
por: Gong, Pin, et al.
Publicado: (2022)

Nesfatin-1 protects H9c2 cardiomyocytes against cobalt chloride-induced hypoxic injury by modulating the MAPK and Notch1 signaling pathways
por: Li, Mingchen, et al.
Publicado: (2021)

Protective effect of mangiferin on myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats: role of AGE-RAGE/MAPK pathways
por: Suchal, Kapil, et al.
Publicado: (2017)

Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function
por: Zhang, Yingmei, et al.
Publicado: (2012)

Galectin-3 Inhibition Ameliorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice
por: Zhu, Ning, et al.
Publicado: (2022)

Exercise protects against diabetic cardiomyopathy by the inhibition of the endoplasmic reticulum stress pathway in rats
por: Chengji, Wang, et al.
Publicado: (2018)

Aldosterone Antagonists in Monotherapy Are Protective against Streptozotocin-Induced Diabetic Nephropathy in Rats
por: Banki, Nora F., et al.
Publicado: (2012)

Streptozotocin-Induced Type 1 and 2 Diabetes Mellitus Mouse Models Show Different Functional, Cellular and Molecular Patterns of Diabetic Cardiomyopathy
por: Marino, Fabiola, et al.
Publicado: (2023)

Polysaccharides from Liriopes Radix ameliorate streptozotocin-induced type I diabetic nephropathy via regulating NF-κB and p38 MAPK signaling pathways
por: Lu, Hung-Jen, et al.
Publicado: (2014)

Cardio-Protective Role of Gingerol along with Prominent Anti-Diabetic Cardiomyopathy Action in A Streptozotocin-Induced Diabetes Mellitus Rat Model
por: Yu, Li-Ya, et al.
Publicado: (2017)

Cardiomyopathy in offspring of diabetic rats is associated with activation of the MAPK and apoptotic pathways
por: Reinking, Benjamin E, et al.
Publicado: (2009)

Bu-Shen-Huo-Xue Decoction Ameliorates Diabetic Nephropathy by Inhibiting Rac1/PAK1/p38MAPK Signaling Pathway in High-Fat Diet/Streptozotocin-Induced Diabetic Mice
por: Wang, Weisong, et al.
Publicado: (2020)

The Tissue Distribution of Nesfatin-1/NUCB2 in Mouse
por: Kim, Jinhee, et al.
Publicado: (2014)

Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy
por: Hadova, Katarina, et al.
Publicado: (2021)

L-Glutamine Supplementation Prevents the Development of Experimental Diabetic Cardiomyopathy in Streptozotocin-Nicotinamide Induced Diabetic Rats
por: Badole, Sachin L., et al.
Publicado: (2014)

Triptolide improves systolic function and myocardial energy metabolism of diabetic cardiomyopathy in streptozotocin-induced diabetic rats
por: Liang, Zhongshu, et al.
Publicado: (2015)

Retraction Note: Mitochondrial aldehyde dehydrogenase (ALDH2) protects against streptozotocin-induced diabetic cardiomyopathy: role of GSK3β and mitochondrial function
por: Zhang, Yingmei, et al.
Publicado: (2022)

Protective effect of ganoderic acid against the streptozotocin induced diabetes, inflammation, hyperlipidemia and microbiota imbalance in diabetic rats
por: Ren, Lei
Publicado: (2019)

Circulating Nesfatin-1 Levels and Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Zhai, Ting, et al.
Publicado: (2017)

Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway
por: Zhang, Chenyang, et al.
Publicado: (2022)

FTZ Ameliorates Diabetic Cardiomyopathy by Inhibiting Inflammation and Cardiac Fibrosis in the Streptozotocin-Induced Model
por: Wang, Lexun, et al.
Publicado: (2021)

Urolithin A prevents streptozotocin-induced diabetic cardiomyopathy in rats by activating SIRT1
por: Albasher, Gadah, et al.
Publicado: (2022)

Protective Effects of Chromium Picolinate Against Diabetic-Induced Renal Dysfunction and Renal Fibrosis in Streptozotocin-Induced Diabetic Rats
por: Qi, Shan Shan, et al.
Publicado: (2020)

Protective role of glibenclamide against nicotinamide-streptozotocin induced nuclear damage in diabetic Wistar rats
por: Rabbani, Syed Imam, et al.
Publicado: (2010)

Protease-activated receptor-1 deficiency protects against streptozotocin-induced diabetic nephropathy in mice
por: Waasdorp, Maaike, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ujldjihsatllk8eto0i1vddmdh